Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Molecular Predictors of Lung Cancer Behavior. (SPORE)

Multiple Cancer Types

Lung, Non Small Cell, Small Cell
N/A
Massion, Pierre
NCT00898313
VICCTHO0398

Molecular Fingerprinting of Lung Cancer (SPORE)

Multiple Cancer Types

Lung, Non Small Cell
N/A
Massion, Pierre
NCT00897117
VICCTHO0136

LIBERTI: Role of Circulating Tumor DNA (ctDNA) from LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation

Multiple Cancer Types

Lung, Non Small Cell, Phase I
N/A
Massion, Pierre
VICCTHO1868

Long Term Follow-up for Early Detection of Lung Cancer in Current or Former Smokers

Lung

This research trial studies the long term follow-up for early detection of lung cancer in current or former smokers. Following up on smokers by collecting and analyzing specimens in the laboratory, performing chest computed tomography (CT) scans, as well as reviewing medical records may help doctors detect lung cancer at an earlier stage.
Lung
N/A
Massion, Pierre
NCT03181256
VICCTHO1730

Screening Methods for Early Diagnosis of Lung Cancer in Current or Former Smokers

Multiple Cancer Types

This trial studies methods of detecting lung cancer at an earlier stage in current or former smokers with a special type of computed tomography (CT) scan and by testing genes and proteins in biospecimens (blood, urine, sputum, and tissue samples) collected at the time of bronchoscopy (examination of the airway). Analyzing these methods may provide an early detection of lung cancer in current or former smokers when it is more amenable to a cure.
Lung, Miscellaneous, Non Small Cell
N/A
Massion, Pierre
NCT01475500
VICCTHO1078

18F-FSPG PET / CT in Imaging Patients with Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

Lung

This phase II trial compares fluorine F 18 L-glutamate derivative BAY94-9392 (18F-FSPG) positron emission tomography (PET) / computed tomography (CT) to the standard of care fludeoxyglucose F-18 (18F-FDG) PET / CT in imaging patients with newly diagnosed lung cancer or indeterminate pulmonary nodules. PET / CT uses a radioactive glutamate (one of the common building blocks of protein) called 18F-FSPG which may be able to recognize differences between tumor and healthy tissue. Since tumor cells are growing, they need to make protein, and other building blocks, for cell growth that are made from glutamate and other molecules. PET / CT using a radioactive glutamate may be a more effective method of diagnosing lung cancer than the standard PET / CT using a radioactive glucose (sugar), such as 18F-FDG.
Lung
II
Massion, Pierre
NCT02448225
VICCTHO1524

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: